Aliskiren (CED0004847)

Record Information
Version1.0
Creation Date2016-05-25 18:26:23 UTC
Update Date2026-08-22 10:26:31 UTC
Accession NumberCHEM022271
Identification
Common NameAliskiren
ClassSmall Molecule
Description
Aliskiren is an organic compound with the chemical formula C30H53N3O6. Aliskiren belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 551.76 g/mol, Aliskiren is a heavy molecule. This compound acts as an inhibitor of the protein target Renin (REN). It is found in or released from four recorded sources, including pharmaceuticals and veterinary products such as agents acting on the renin-angiotensin system and angiotensin II receptor blockers (ARBs). Additionally, it is associated with household cleaning and consumer products, specifically other smoking requisites and non electric simulated smoking devices. The recorded route of exposure for Aliskiren is oral.
Contaminant TypeNot Available
Chemical Structure
Synonyms
ValueSource
SPP 100ChEBI
RasilezKegg
2(S),4(S),5(S),7(S)-N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-(4-methoxy-3-(3-methoxypropoxy)phenyl)octanamid hemifumarateHMDB
TekturnaHMDB
Chemical FormulaC30H53N3O6
Average Molecular Mass551.758 g/mol
Monoisotopic Mass551.393 g/mol
CAS Registry Number173334-57-1
IUPAC Name(2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide
Traditional Namealiskiren
SMILESCOCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1
InChI IdentifierInChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1
InChI KeyUXOWGYHJODZGMF-QORCZRPOSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as delta amino acids and derivatives. Delta amino acids and derivatives are compounds containing a carboxylic acid group and an amino group at the C5 carbon atom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentDelta amino acids and derivatives
Alternative Parents
Substituents
  • Delta amino acid or derivatives
  • Phenylbutylamine
  • Beta amino acid or derivatives
  • Phenol ether
  • Phenoxy compound
  • Methoxybenzene
  • Anisole
  • Aralkylamine
  • Alkyl aryl ether
  • Fatty acyl
  • Benzenoid
  • Fatty amide
  • N-acyl-amine
  • Monocyclic benzene moiety
  • Secondary carboxylic acid amide
  • Secondary alcohol
  • Primary carboxylic acid amide
  • Carboxamide group
  • 1,2-aminoalcohol
  • Ether
  • Dialkyl ether
  • Organic nitrogen compound
  • Primary aliphatic amine
  • Organonitrogen compound
  • Organooxygen compound
  • Primary amine
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Amine
  • Organic oxygen compound
  • Alcohol
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.0021 g/LALOGPS
logP3.87ALOGPS
logP3.12ChemAxon
logS-5.4ALOGPS
pKa (Strongest Acidic)14.56ChemAxon
pKa (Strongest Basic)9.57ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area146.13 ŲChemAxon
Rotatable Bond Count19ChemAxon
Refractivity154.32 m³·mol⁻¹ChemAxon
Polarizability64.25 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-001c-6393230000-97b551a81f81203eb590Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0a4i-7469235000-e2f24f487b627d936958Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0uxr-0700090000-7a3148e765b056fbdbb2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-3901100000-cb596bd3c4d4c9e1c01fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-7911000000-f660df43e70edac0517aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0079-5910000000-d3e40bdba155982e7e43Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00dr-3900000000-8bce7f74c2390532741cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-3900000000-12d8e1ded46f53c83764Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0019-0000950000-e45c32fa4cac95668993Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0v4i-4920100000-82dc644fa438b541d394Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0fk9-9810000000-c1c9bdda4686e3e603b1Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-3900000000-f5052afca313a2f0c68bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0f9f-7900000000-12cc981f01c6cad986b8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-9300000000-a3026b636a234fc9ae1fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-3901100000-c2124c275ccd15a80570Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-7911000000-c220003a0ea5dad03825Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0v4i-4920100000-82dc644fa438b541d394Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0019-0000950000-e45c32fa4cac95668993Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0fk9-9810000000-c1c9bdda4686e3e603b1Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0uxr-0700090000-8bc5ad295a956b9a03d7Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0v59-0100190000-edccaa882cf6d1494583Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-06du-5222980000-ca6eae1e516509273ed5Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00di-9113000000-f31f900357cbcf26757aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0udi-1000390000-f458496a198165e95ae5Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0ikc-8262960000-b870004b843afb100552Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0096-9465700000-39d6ecfc74ef81c49d7eNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0v7i-1560390000-ff75398ffd268dba9afeNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0006-9135450000-057d7807577cdd57a326Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00gl-9324100000-6f7311112eb70f00f803Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0imi-0000950000-96e2d3568601604d4104Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03ei-0009500000-f668d070bf92a9ef826cNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01ox-1009500000-94ee2958f5e63ef9b88eNot AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
943.0Log mg/kg[530:1700]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
296Angiotensin ii receptor blockers (arbs)Healthcare, pharmaceuticals & veterinary productsNot Available
297Agents acting on the renin-angiotensin systemHealthcare, pharmaceuticals & veterinary productsNot Available
559Non Electric Simulated Smoking DevicesHousehold cleaning & consumer productsNot Available
560Other Smoking RequisitesHousehold cleaning & consumer productsNot Available
Pathways
1 pathway
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureReninQ7M3D2Oryctolagus cuniculusPredicted (SEA)0.0778492
Click to view 3D structureReninQ9TSZ1Callithrix jacchusPredicted (SEA)0.0778492
Renin structureClick to view 3D structureReninP00797HumansPredicted (SEA)0.856341
Click to view 3D structureRenin-1P06281Mus musculusPredicted (SEA)0.155698
Click to view 3D structureReninQ6DLW5Macaca mulattaPredicted (SEA)0.155698
Cathepsin D structureClick to view 3D structureCathepsin DP07339HumansPredicted (SEA)13.7793
Cathepsin E structureClick to view 3D structureCathepsin EP14091HumansPredicted (SEA)8.01847
Beta-secretase 1 structureClick to view 3D structureBeta-secretase 1P56817HumansPredicted (SEA)44.3741
Click to view 3D structurePepsin A-5P0DJD9HumansPredicted (SEA)0.856341
Click to view 3D structureReninP08424Rattus norvegicusPredicted (SEA)19.8516
Click to view 3D structureProteaseQ9YQ12Human immunodeficiency virus 1Predicted (SEA)18.7617
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)1700.07
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP35372HumansPredicted (SEA)989.931
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)1492.06
Alpha-2A adrenergic receptor structureClick to view 3D structureAlpha-2A adrenergic receptorP08913HumansPredicted (SEA)980.9
Click to view 3D structureReninQ6DLS0Macaca fascicularisPredicted (SEA)0.700643
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)2139.06
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)1863.87
Alpha-1A adrenergic receptor structureClick to view 3D structureAlpha-1A adrenergic receptorP35348HumansPredicted (SEA)1029.17
Cytochrome P450 2C9 structureClick to view 3D structureCytochrome P450 2C9P11712HumansPredicted (SEA)3822.79
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)1652.74
5-hydroxytryptamine receptor 2B structureClick to view 3D structure5-hydroxytryptamine receptor 2BP41595HumansPredicted (SEA)1845.73
Cytochrome P450 2C19 structureClick to view 3D structureCytochrome P450 2C19P33261HumansPredicted (SEA)2870.3
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP28223HumansPredicted (SEA)2386.62
Beta-2 adrenergic receptor structureClick to view 3D structureBeta-2 adrenergic receptorP07550HumansPredicted (SEA)796.086
Concentrations
Not Available
External Links
DrugBank IDDB09026
HMDB IDHMDB0015387
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDC41
Wikipedia LinkAliskiren
Chemspider ID4591452
ChEBI ID601027
PubChem Compound ID5493444
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=19358611
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=19457666
3. Vaidyanathan S, Jarugula V, Dieterich HA, Howard D, Dole WP: Clinical pharmacokinetics and pharmacodynamics of aliskiren. Clin Pharmacokinet. 2008;47(8):515-31.
4. Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP: Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation. 2005 Mar 1;111(8):1012-8. Epub 2005 Feb 21.
5. Staessen JA, Li Y, Richart T: Oral renin inhibitors. Lancet. 2006 Oct 21;368(9545):1449-56.